Bringing about a higher level of transparency and accountability in provincial and federal governments to help protect taxpayers from abuse
The pharmaceutical giant that misled physicians and patients about the addictive properties of its top-selling drug OxyContin, fuelling an overdose crisis that has devastated communities across North America, will stop marketing opioids to U.S. physicians.
However, the new policy does not extend into Canada.
Purdue Pharma L.P. announced the change in a statement issued on the weekend.
Read more at The Globe and Mail
Officials in Tennessee are coming after drug makers, specifically Purdue Pharma, alleging dishonest marketing of their medications hooked the region on opioids.
The district attorneys general for five judicial districts in the eastern portion of the state filed the lawsuit Sept. 29, which focuses on Purdue Pharma, the manufacturers of OxyContin. Jared Effler, district attorney general for Tennessee’s Eighth Judicial District, is spearheading the legal effort for the region, which he says is “one of the hardest-hit areas in the opioid epidemic that is plaguing the nation,” reports Bristol Herald Courier.
Read more at The Daily Caller